Main Industry
Biotechnology
Main Product/Service
1. Protein Drugs
2. Small Molecule Pharmaceuticals
3. Generic Drugs
2. Small Molecule Pharmaceuticals
3. Generic Drugs
Founded Year
2014
Unified Business No.
24626617
Status
Active
Number of Employees
0
Total Paid-in
Capital
1,181,902,050 (NT$)
Location of Company
Taiwan
, Hsinchu County
Exit Status
Emerging Stock Exchange(2021)
Information such as company name, company status, responsible person, year of establishment, paid-in capital, and registered address is sourced from the Commercial and Industrial Registration Office of the Ministry of Economic Affairs; listing status includes emerging stock, M&A, and IPO; overseas development is provided by the startup itself.
Notice: This data is compiled from public sources for reference only. We have no direct affiliation with the company and are not their contact person.
Exclusive content for members
Members-only content. Please log in to access.
About the Company
UBI Pharma Inc., established on July 31, 2014, is a trailblazing force in the pharmaceutical industry. We take pride in being the first pharmaceutical company in Asia (excluding Japan) to successfully pass the rigorous US FDA inspection for our injection filling production line. With over two decades of experience in the pharmaceutical sector, we have forged a path dedicated to pioneering long-acting protein drugs and specialized injectables. Our dedicated team, comprised of nearly 300 professionals, with almost 30% holding master's degrees or higher, operates from our headquarters and state-of-the-art manufacturing center situated in Hsinchu Industrial Park, covering an impressive 240,000 square feet. Additionally, we have strategically established clinical centers and business hubs in Taipei.
